Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Pathological mTOR mutations impact cortical development.

Tarkowski B, Kuchcinska K, Blazejczyk M, Jaworski J.

Hum Mol Genet. 2019 Jul 1;28(13):2107-2119. doi: 10.1093/hmg/ddz042.

PMID:
30789219
2.

Adaptor Complex 2 Controls Dendrite Morphology via mTOR-Dependent Expression of GluA2.

Koscielny A, Malik AR, Liszewska E, Zmorzynska J, Tempes A, Tarkowski B, Jaworski J.

Mol Neurobiol. 2018 Feb;55(2):1590-1606. doi: 10.1007/s12035-017-0436-3. Epub 2017 Feb 11.

3.

A cell-autonomous tumour suppressor role of RAF1 in hepatocarcinogenesis.

Jeric I, Maurer G, Cavallo AL, Raguz J, Desideri E, Tarkowski B, Parrini M, Fischer I, Zatloukal K, Baccarini M.

Nat Commun. 2016 Dec 21;7:13781. doi: 10.1038/ncomms13781.

4.

Spatiotemporal characterization of mTOR kinase activity following kainic acid induced status epilepticus and analysis of rat brain response to chronic rapamycin treatment.

Macias M, Blazejczyk M, Kazmierska P, Caban B, Skalecka A, Tarkowski B, Rodo A, Konopacki J, Jaworski J.

PLoS One. 2013 May 28;8(5):e64455. doi: 10.1371/journal.pone.0064455. Print 2013.

5.

Raf kinases in cancer-roles and therapeutic opportunities.

Maurer G, Tarkowski B, Baccarini M.

Oncogene. 2011 Aug 11;30(32):3477-88. doi: 10.1038/onc.2011.160. Epub 2011 May 16. Review.

PMID:
21577205

Supplemental Content

Loading ...
Support Center